Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial
P. Mease, P. Helliwell, Paula Silwinska-Stanczyk, M. Miakisz +11 more
2023Arthritis & Rheumatology56 citations Open access
Semantic Scholar

